Hannah Johnson, BS

University of Nebraska Medical Center
Omaha, Nebraska, United States

I am a 3rd-year (G1) MD-PhD student at the University of Nebraska Medical Center. My current research focuses on understanding how post-translational modifications of native proteins activate macrophage signaling pathways and how other cell types are affected in rheumatoid arthritis.

Presentation(s):

• 0921: Fibrinogen Co-Modified with Malondialdehyde-Acetaldehyde and Citrulline Promotes Pro-Inflammatory Macrophage Differentiation Through p38 and NF-κB Signaling

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose

• 1650: Malondialdehyde-Acetaldehyde and Citrulline Modified Proteins are Overexpressed in Cardiac Tissues in Rheumatoid Arthritis-Associated Heart Failure and Mediate Endothelial Cell Dysfunction

  Monday, October 27, 2025
  1:00 PM - 1:15 PM Central Time

  Disclosure(s): No financial relationships with ineligible companies to disclose